- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Latent class analysis of 216 patients with adult-onset Still’s disease ; volume:24 ; number:1 ; day:3 ; month:1 ; year:2022 ; pages:1-10 ; date:12.2022
Arthritis Research & Therapy ; 24, Heft 1 (3.1.2022), 1-10, 12.2022
- Urheber
-
Sugiyama, Takahiro
Furuta, Shunsuke
Hiraguri, Masaki
Ikeda, Kei
Inaba, Yosuke
Kagami, Shin-ichiro
Kita, Yasuhiko
Kobayashi, Kei
Kobayashi, Yoshihisa
Kurasawa, Kazuhiro
Nakagomi, Daiki
Nawata, Yasushi
Kawasaki, Yohei
Shiko, Yuki
Sugiyama, Takao
Nakajima, Hiroshi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-021-02708-3
- URN
-
urn:nbn:de:101:1-2022042119245036704462
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sugiyama, Takahiro
- Furuta, Shunsuke
- Hiraguri, Masaki
- Ikeda, Kei
- Inaba, Yosuke
- Kagami, Shin-ichiro
- Kita, Yasuhiko
- Kobayashi, Kei
- Kobayashi, Yoshihisa
- Kurasawa, Kazuhiro
- Nakagomi, Daiki
- Nawata, Yasushi
- Kawasaki, Yohei
- Shiko, Yuki
- Sugiyama, Takao
- Nakajima, Hiroshi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pregnancy-Associated Onset of Adult-Onset Still's Disease
Response letter to “Latent class analysis of 216 patients with adult-onset Still’s disease” by Sugiyama et al
Therapeutic responses and prognosis in Korean adult-onset Still’s disease
Bilateral dacryoadenitis in adult-onset Still’s disease: A case report
Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease
Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still’s Disease
Suppurative necrotizing granulomatous lymphadenitis in adult-onset Still’s disease: a case report
A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
Adult-onset Still’s disease with concurrent acute necrotizing encephalopathy: a case report
Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy
Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
Adult-onset Still’s disease with multiple lymphadenopathy: a case report and literature review
Pregnancy-Associated Onset of Adult-Onset Still's Disease
Response letter to “Latent class analysis of 216 patients with adult-onset Still’s disease” by Sugiyama et al
Therapeutic responses and prognosis in Korean adult-onset Still’s disease
Bilateral dacryoadenitis in adult-onset Still’s disease: A case report
Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease
Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still’s Disease
Suppurative necrotizing granulomatous lymphadenitis in adult-onset Still’s disease: a case report
A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
Adult-onset Still’s disease with concurrent acute necrotizing encephalopathy: a case report
Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy
Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
Adult-onset Still’s disease with multiple lymphadenopathy: a case report and literature review
Pregnancy-Associated Onset of Adult-Onset Still's Disease
Response letter to “Latent class analysis of 216 patients with adult-onset Still’s disease” by Sugiyama et al
Therapeutic responses and prognosis in Korean adult-onset Still’s disease
Bilateral dacryoadenitis in adult-onset Still’s disease: A case report
Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease
Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still’s Disease
Suppurative necrotizing granulomatous lymphadenitis in adult-onset Still’s disease: a case report
A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
Adult-onset Still’s disease with concurrent acute necrotizing encephalopathy: a case report
Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy
Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease